NSC |
Compound |
Enrichment |
Correlation |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.0287230216965525 |
-0.18862903 |
NSC 743265 |
Null |
0.0287337488682928 |
0.20889068 |
NSC 743962 |
Null |
0.0287337488682928 |
-0.0026813997 |
NSC 746687 |
(2E)-3-(2-phenyl-1H-indol-3-yl)-2-(phenylsulfonyl)acrylonitrile |
0.0287337488682928 |
-0.06871513 |
NSC 749117 |
3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline |
0.0287337488682928 |
0.18023267 |
NSC 756134 |
GSK1023156A |
0.0287337488682928 |
0.054012858 |
NSC 113237 |
Null |
0.0287337488682932 |
0.049278359 |
NSC 125845 |
Null |
0.0287337488682932 |
-0.0067563522 |
NSC 134754 |
Null |
0.0287337488682932 |
0.11199585 |
NSC 154829 |
7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamidoxime, 4-(hydroxyamino)-7-.beta.-D-ribofuranosyl-, monohydrochloride |
0.0287337488682932 |
-0.22942689 |